Hui-mei Chen

TPQ, Taiwan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 38 publications

The Utility of Single-Leg Stance and Five Times Sit-to-Stand Tests in Discriminating Walking Speed Level Among Older Adults in Day Care Centers.

The Utility of Single-Leg Stance and Five Times Sit-to-Stand Tests in Discriminating Walking Speed Level Among Older Adults in Day Care Centers.

Journal: Journal of geriatric physical therapy (2001)

Published: May 14, 2026

ROS-HIF1α-driven glycolytic reprogramming sustains ATP production in Huntington's disease.

ROS-HIF1α-driven glycolytic reprogramming sustains ATP production in Huntington's disease.

Journal: Neurobiology of disease

Published: April 26, 2026

Berbamine hydrochloride as a brain penetrant galectin 3 inhibitor in a model of Huntington's disease.

Berbamine hydrochloride as a brain penetrant galectin 3 inhibitor in a model of Huntington's disease.

Journal: Brain : a journal of neurology

Published: June 30, 2025

Equilibrative nucleoside transporter 2 modulates inosine catabolism to influence astrocyte metabolism and reactivity.

Equilibrative nucleoside transporter 2 modulates inosine catabolism to influence astrocyte metabolism and reactivity.

Journal: Cell reports

Published: December 07, 2023

Exploring the human gut microbiota targets in relation to the use of contemporary antidepressants.

Exploring the human gut microbiota targets in relation to the use of contemporary antidepressants.

Journal: Journal of affective disorders

Published: June 26, 2023

Validation and Comparison of the Informant-Rated and Self-Rated Versions of the Mild Behavioral Impairment Checklist.

Validation and Comparison of the Informant-Rated and Self-Rated Versions of the Mild Behavioral Impairment Checklist.

Journal: Journal of Alzheimer's disease : JAD

Published: October 10, 2022

Galectin-3 aggravates microglial activation and tau transmission in tauopathy.

Galectin-3 aggravates microglial activation and tau transmission in tauopathy.

Journal: The Journal of clinical investigation

Published: September 19, 2022

Exploration of the relationship between gut microbiota and fecal microRNAs in patients with major depressive disorder.

Exploration of the relationship between gut microbiota and fecal microRNAs in patients with major depressive disorder.

Journal: Scientific reports

Published: June 15, 2022

TRAX Provides Neuroprotection for Huntington's Disease Via Modulating a Novel Subset of MicroRNAs.

TRAX Provides Neuroprotection for Huntington's Disease Via Modulating a Novel Subset of MicroRNAs.

Journal: Movement disorders : official journal of the Movement Disorder Society

Published: February 20, 2022

Psychophysiological Effects of Lactobacillus plantarum PS128 in Patients with Major Depressive Disorder: A Preliminary 8-Week Open Trial.

Psychophysiological Effects of Lactobacillus plantarum PS128 in Patients with Major Depressive Disorder: A Preliminary 8-Week Open Trial.

Journal: Nutrients

Published: September 26, 2021

A PIAS1 Protective Variant S510G Delays polyQ Disease Onset by Modifying Protein Homeostasis.

A PIAS1 Protective Variant S510G Delays polyQ Disease Onset by Modifying Protein Homeostasis.

Journal: Movement disorders : official journal of the Movement Disorder Society

Published: July 28, 2021

Equilibrative nucleoside transporter 1 inhibition rescues energy dysfunction and pathology in a model of tauopathy.

Equilibrative nucleoside transporter 1 inhibition rescues energy dysfunction and pathology in a model of tauopathy.

Journal: Acta neuropathologica communications

Published: April 21, 2021

Showing 1-12 of 38

Last Updated: 09/26/2026